MODURETIC 5-50 Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Moduretic 5-50, and what generic alternatives are available?

Moduretic 5-50 is a drug marketed by Merck and is included in one NDA.

The generic ingredient in MODURETIC 5-50 is amiloride hydrochloride; hydrochlorothiazide. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amiloride hydrochloride; hydrochlorothiazide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Moduretic 5-50

A generic version of MODURETIC 5-50 was approved as amiloride hydrochloride; hydrochlorothiazide by BARR on May 10^th, 1988.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for MODURETIC 5-50?
What are the global sales for MODURETIC 5-50?
What is Average Wholesale Price for MODURETIC 5-50?

Summary for MODURETIC 5-50

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	6
Clinical Trials:	2
Patent Applications:	114
DailyMed Link:	MODURETIC 5-50 at DailyMed

Drug patent expirations by year for MODURETIC 5-50

Recent Clinical Trials for MODURETIC 5-50

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
GlaxoSmithKline	Phase 1
Centre Hospitalier Universitaire de Saint Etienne	Phase 4

See all MODURETIC 5-50 clinical trials

US Patents and Regulatory Information for MODURETIC 5-50

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Merck	MODURETIC 5-50	amiloride hydrochloride; hydrochlorothiazide	TABLET;ORAL	018201-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for MODURETIC 5-50

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Merck	MODURETIC 5-50	amiloride hydrochloride; hydrochlorothiazide	TABLET;ORAL	018201-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for MODURETIC 5-50

See the table below for patents covering MODURETIC 5-50 around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
United Kingdom	1050729		⤷ Sign Up
Norway	134524		⤷ Sign Up
Switzerland	489495	Verfahren zur Herstellung von 3-Indolyl-niederaliphatischen Säuren	⤷ Sign Up
Denmark	112238		⤷ Sign Up
Germany	1695493		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for MODURETIC 5-50

Recent Clinical Trials for MODURETIC 5-50

Make Better Decisions: Try a trial or see plans & pricing